New Insulin Sensitizers as a Golden Combination With Glp-1 & Weight Loss Therapies
Time: 9:30 am - 10:00 am
day: Day One
Details:
- Discussing novel oral insulin sensitizers targeting the mitochondrial pyruvate carrier to improve insulin sensitivity by shifting mitochondrial metabolism, increasing insulin response, and enhancing mitochondrial function
- Exploring insulin sensitizers beyond glycaemic control such as their potential to increase lean muscle mass and inflammation modulation
- Developing potent insulin-sensitising drugs that can be used in combination with GLP-1 receptor agonists to meet the large unmet need in the management of individuals with type 2 diabetes
